RejuvenAir - About the company
RejuvenAir is a series F company based in Lexington (United States), founded in 2006. It operates as a Developer of a cryosurgical device for chronic bronchitis and COPD. RejuvenAir has raised $171M in funding from investors like Intersouth Partners, Rose Park Advisors and Ascension Ventures.
Company Details
Developer of a cryosurgical device for chronic bronchitis and COPD. The system delivers small, metered doses of cryogen spray which flash freeze the surface area of damaged airways. It utilizes software-driven dosimetry and catheters to enable the delivery of cryogen spray inside the airways, reducing mucous production, cough, and inflammation in chronic bronchitis and COPD.
- Website
- rejuvenair.com
- Email ID
- *****@rejuvenair.com
- Phone Number
- +1 **********
- Registered Address
- Lexington, Massachusetts
Key Metrics
Founded Year
2006
Location
Lexington, United States
Stage
Series F
Total Funding
$171M in 14 rounds
Latest Funding Round
Investors
Similar Companies
Legal entities associated with RejuvenAir
RejuvenAir is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Csa Medical, Inc. CIN: 262627596 , United States, Active | Feb 24, 2008 | - | 10 (As on Dec 31, 2024) | - |
Sign up to download RejuvenAir's company profile
RejuvenAir's funding and investors
RejuvenAir has raised a total funding of $171M over 14 rounds. Its first funding round was on Jun 2007. RejuvenAir has 9 institutional investors.
Here is the list of recent funding rounds of RejuvenAir:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 30, 2024 | 4801609 | Series F | 8751491 | 2662252 | 4917533 | 6798075 |
Feb 07, 2019 | 5262803 | Conventional Debt | 1102585 | 9897312 | 9968269 | 3455148 |
Feb 07, 2019 | 2012297 | Series E | 7340940 | 9218744 | 4363062 | 1346780 |
Access funding benchmarks and valuations. Sign up today!View details of RejuvenAir's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
RejuvenAir's Investments and acquisitions
RejuvenAir has made no investments or acquisitions yet.
News related to RejuvenAir
Filter this list•
•
CSA Medical: $53 Million (Series D) Raised For Advancing RejuvenAir SystemPulse 2.0•Sep 09, 2024•TVM Capital, RejuvenAir, Yonjin Capital, SV Health Investors and 4 others
•
•
•
Study backs RejuvenAir treatment for bronchitis from CSA MedicalDrug Delivery Business•Sep 06, 2022•RejuvenAir
•
•
CSA Medical Announces Enrollment Milestone In A Mechanism Of Action StudyMedical Device News•Nov 11, 2020•RejuvenAir
•
•
RejuvenAir® System for COPD Patients with Chronic Bronchitis Earns CE MarkMedical Device News•Dec 02, 2019•RejuvenAir, CSA Medical
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about RejuvenAir
Explore our recently published companies
- Becsmd - Baltimore based, 2014 founded, Unfunded company
- Capitalcityconstructionllc - United States based, Unfunded company
- Geprolux - Luxembourg based, Funding Raised company
- Daleoffice - United Kingdom based, Unfunded company
- Westructure - United Kingdom based, Unfunded company
- Bradshawcc - Belgium based, 1981 founded, Unfunded company
